524400 — Ishita Drugs And Industries Balance Sheet
0.000.00%
- IN₹223.17m
- IN₹178.71m
- IN₹149.97m
- 50
- 47
- 46
- 45
Annual balance sheet for Ishita Drugs And Industries, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 54.2 | 84.8 | 65.5 | 78.7 | 83.5 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 18.9 | 5.75 | 20 | 7 | 21.4 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 79.9 | 100 | 102 | 96.6 | 150 |
Net Property, Plant And Equipment | 9.96 | 8.85 | 8.89 | 8.05 | 8.79 |
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Total Assets | 92.6 | 113 | 114 | 108 | 163 |
Accounts Payable | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 14.3 | 26.3 | 22.1 | 8.67 | 54 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Liabilities | 14.7 | 26.6 | 22.3 | 8.87 | 55.1 |
Common Stock | |||||
Other Equity | |||||
Total Equity | 77.9 | 86 | 91.7 | 99.2 | 108 |
Total Liabilities & Shareholders' Equity | 92.6 | 113 | 114 | 108 | 163 |
Total Common Shares Outstanding |